ClinicalTrials.gg
CompletedNCT02629614Updated Jul 18, 2023Results posted

Cala ONE Device for Essential Tremor

An interventional study of Cala ONE Device in Essential Tremor, sponsored by Cala Health, Inc.. Completed at 4 sites in United States. Open to participants aged 22 Years and older. Per ClinicalTrials.gov, last updated 2023-07-18.

Sponsored by Cala Health, Inc. · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
93
Allocation
Randomized
Ages
22 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 146 studies in Essential Tremor with a site in United States — 40 open to participants now, 46 under way, 1 of them phase 3. Essential Tremor · United States.

Enrollment
23rd of 104
93 · median 30
Started
2016
with 8 others
No phase
60 of 146
22 open now
Registered
58th of 146
by date
Lead sponsor
5 of 146
Cala Health, Inc.

Among the 146 studies in Essential Tremor with a site in United States, this one is the 23rd largest by enrollment of the 104 interventional ones that give a count, is one of 9 that started in 2016, is one of 60 with no phase, and was the 58th registered.

Essential Tremor

272 studies on the registry are indexed under Essential Tremor; 75 are open to participants now.

Browse Essential Tremor studies →

Open to participants now

40 of the 146 studies in Essential Tremor with a site in United States are open now. Recruiting first, the newest first:

35 more — sign in →

All 40 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 61 Essential Tremor studies recruiting now, 32 (52%) set no upper age limit and 5 (8%) stop at 75 or younger; 8 take children under 18; 7 take healthy volunteers.

This study: 22 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 146 studies in Essential Tremor with a site in United States, or all of them as a file.
02

Study summary

This study evaluates the safety and effectiveness of the Cala ONE device to aid in the symptomatic relief of hand tremors in adult essential tremor subjects. This study is a prospective, randomized, double-blinded, sham-controlled study.

03

Conditions studied

  • Essential Tremor

Browse trials for

04

Who can participate

Ages eligible
22 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. 22 years or older
  2. A diagnosis of essential tremor as confirmed from clinical history and examination by a movement disorder neurologist
  3. Signed
  4. At least one hand exhibiting kinetic tremor ≥ 2 as assessed by the TETRAS Archimedes spiral task completed during the baseline evaluation, as assessed by the Investigator in-person.
  5. Score of 3 or above in any one of the items of the Bain \& Findley ADL Scale

Exclusion criteria

Exclusion Criteria:

  1. Implanted electrical medical device, such as a pacemaker, defibrillator, or deep brain stimulator
  2. Previous thalamotomy procedure, including Stereotactic Thalamotomy, Gamma Knife Radiosurgical Thalamotomy, and focused ultrasound, for the treatment of tremor
  3. Suspected or diagnosed epilepsy or other seizure disorder
  4. Pregnant
  5. Swollen, infected, inflamed areas, or skin eruptions, open wounds, or cancerous lesions of skin at stimulation site
  6. Peripheral neuropathy affecting the tested upper extremity
  7. Alcoholism (score of 4 or higher on )
  8. Other possible causes of tremor, including Parkinson's disease, drug-induced, enhanced physiological tremor, dystonia
  9. Other neurodegenerative disease like Parkinson-plus syndromes suspected on neurological examination. These include: multisystem atrophy, progressive supranuclear palsy, dementia with Lewy bodies, and cortical basal ganglionic degeneration
  10. Changes in medication for tremor within 1 month prior to study enrollment
  11. Change in antidepressant medication within 3 months prior to study enrollment
  12. Botulinum Toxin injection for hand tremor within 6 months prior to study enrollment
  13. Current participation in any other interventional research study
  14. Previous participation in any other Cala Health interventional research study
  15. Alcohol or caffeine consumption within 12 hours of study enrollment

Subjects already taking medications for their essential tremor will remain on their medications during the study with no changes in medication type or dosage levels.

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
93 participants (actual)

Study arms

  • Experimental
    TAPS Stimulation

    Temporal Afferent Patterned Stimulation (TAPS) is alternating bursts of TENS stimulation applied to the radial and median nerves of a subject's wrist using the Cala ONE device.

    Device: Cala ONE Device

  • Sham comparator
    Sham Stimulation

    0 amplitude stimulation applied to the radial and median nerves of a subject's wrist using the Cala ONE device.

    Device: Cala ONE Device

Interventions

  • DeviceCala ONE Device

    The Cala ONE device is a wrist-worn stimulator which applies transcutaneous electrical stimulation non-invasively to the median and radial nerves of an individual through disposable hydrogel electrodes.

06

What researchers measure

Primary outcomes

  1. Change in TETRAS Spiral Rating After Stimulation

    The primary effectiveness variable is the change in tremor severity immediately after the stimulation session compared to baseline (immediately prior to stimulation) as measured using the TETRAS Archimedes spiral task (assessed by 3 blinded raters). The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.

    Time frame: Immediately before and after 40 minute stimulation session

Secondary outcomes

  1. Change in TETRAS Spiral Rating During Stimulation

    An additional analysis variable is the change in tremor severity during the stimulation session (30 minutes into stimulation session) compared to baseline (immediately prior to stimulation) as measured using the TETRAS Archimedes spiral task (assessed by 3 blinded raters). The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.

    Time frame: Immediately before and 30 minutes into stimulation session

  2. Self-report Improvement

    The percentage of subjects in the treatment group indicating improvement on the CGI-I Scale will be compared to the sham group. The Clinical Global Impression - Improvement (GGI-I) scale evaluates a clinician's rating of tremor improvement noted in the subject, as a result of the treatment. The scale ranges from 1 (very much improved) to 7 (very much worse).

    Time frame: Immediately before and after 40 minute stimulation session

Other outcomes

  1. Change in Kinetic Tremor

    The change in tremor severity on the kinetic tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.

    Time frame: Immediately before and after 40 minute stimulation session

  2. Change in Kinetic Tremor

    The change in tremor severity on the kinetic tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.

    Time frame: Immediately before and 30 minutes into stimulation session

  3. Change in Lateral "Wing Beating" Postural Tremor

    The change in tremor severity in the lateral "wing beating" postural tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.

    Time frame: Immediately before and after 40 minute stimulation session

  4. Change in Lateral "Wing Beating" Postural Tremor

    The change in tremor severity in the lateral "wing beating" postural tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.

    Time frame: Immediately before and 30 minutes into stimulation session

  5. Change in Forward Outstretched Postural Tremor

    The change in tremor severity on outstretched tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.

    Time frame: Immediately before and after 40 minute stimulation session

  6. Change in Forward Outstretched Postural Tremor

    The change in tremor severity on outstretched tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.

    Time frame: Immediately before and 30 minutes into stimulation session

  7. Change in Bain & Findley ADL: Use a Spoon to Drink Liquid

    The change in tremor severity on drinking liquid with a spoon as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.

    Time frame: Immediately before and after 40 minute stimulation session

  8. Change in Bain & Findley ADL: Hold a Cup of Liquid

    The change in tremor severity on holding a cup of liquid as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.

    Time frame: Immediately before and after 40 minute stimulation session

  9. Change in Bain & Findley ADL: Pouring

    The change in tremor severity on pouring as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.

    Time frame: Immediately before and after 40 minute stimulation session

  10. Change in Bain & Findley ADL: Dialing

    The change in tremor severity on dialing a telephone as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.

    Time frame: Immediately before and after 40 minute stimulation session

  11. Change in Bain & Findley ADL: Picking up Change

    The change in tremor severity on picking up change as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.

    Time frame: Immediately before and after 40 minute stimulation session

  12. Change in Bain & Findley ADL: Inserting Plug Into Socket

    The change in tremor severity on inserting a plug into a socket as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.

    Time frame: Immediately before and after 40 minute stimulation session

  13. Change in Bain & Findley ADL: Unlocking

    The change in tremor severity on unlocking a lock with a key as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.

    Time frame: Immediately before and after 40 minute stimulation session

07

Results

Posted Jul 18, 2023

Participant flow

Participant flow — Overall Study
MilestoneTAPS StimulationSham Stimulation
Started4845
Completed4844
Not completed01

Outcome measures

PrimaryChange in TETRAS Spiral Rating After Stimulation

The primary effectiveness variable is the change in tremor severity immediately after the stimulation session compared to baseline (immediately prior to stimulation) as measured using the TETRAS Archimedes spiral task (assessed by 3 blinded raters). The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.

Time frame:
Immediately before and after 40 minute stimulation session
Reported as:
Mean · score on a scale
Change in TETRAS Spiral Rating After Stimulation
score on a scaleTAPS StimulationSham Stimulation
Baseline2.95 ± 0.682.63 ± 0.52
Post Stimulation2.41 ± 12.23 ± 0.80
SecondaryChange in TETRAS Spiral Rating During Stimulation

An additional analysis variable is the change in tremor severity during the stimulation session (30 minutes into stimulation session) compared to baseline (immediately prior to stimulation) as measured using the TETRAS Archimedes spiral task (assessed by 3 blinded raters). The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.

Time frame:
Immediately before and 30 minutes into stimulation session
Reported as:
Mean · score on a scale
Change in TETRAS Spiral Rating During Stimulation
score on a scaleTAPS StimulationSham Stimulation
Baseline2.95 ± 0.682.63 ± 0.52
During Stimulation2.58 ± 0.902.26 ± 0.67
SecondarySelf-report Improvement

The percentage of subjects in the treatment group indicating improvement on the CGI-I Scale will be compared to the sham group. The Clinical Global Impression - Improvement (GGI-I) scale evaluates a clinician's rating of tremor improvement noted in the subject, as a result of the treatment. The scale ranges from 1 (very much improved) to 7 (very much worse).

Time frame:
Immediately before and after 40 minute stimulation session
Reported as:
Count of participants · Participants
Self-report Improvement
ParticipantsTAPS StimulationSham Stimulation
Self-report Improvement3523
Other pre-specifiedChange in Kinetic Tremor

The change in tremor severity on the kinetic tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.

Time frame:
Immediately before and after 40 minute stimulation session
Reported as:
Mean · score on a scale
Change in Kinetic Tremor
score on a scaleTAPS StimulationSham Stimulation
Baseline2.29 ± 0.472.27 ± 0.47
Change after stimulation-0.53 ± 0.59-0.34 ± 0.43
Other pre-specifiedChange in Kinetic Tremor

The change in tremor severity on the kinetic tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.

Time frame:
Immediately before and 30 minutes into stimulation session
Reported as:
Mean · score on a scale
Change in Kinetic Tremor
score on a scaleTAPS StimulationSham Stimulation
Baseline2.29 ± 0.472.27 ± 0.47
Change during stimulation-0.50 ± 0.51-0.53 ± 0.59
Other pre-specifiedChange in Lateral "Wing Beating" Postural Tremor

The change in tremor severity in the lateral "wing beating" postural tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.

Time frame:
Immediately before and after 40 minute stimulation session
Reported as:
Mean · score on a scale
Change in Lateral "Wing Beating" Postural Tremor
score on a scaleTAPS StimulationSham Stimulation
Baseline2.29 ± 0.702.16 ± 0.57
Change after stimulation-0.56 ± 0.72-0.36 ± 0.54
Other pre-specifiedChange in Lateral "Wing Beating" Postural Tremor

The change in tremor severity in the lateral "wing beating" postural tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.

Time frame:
Immediately before and 30 minutes into stimulation session
Reported as:
Mean · score on a scale
Change in Lateral "Wing Beating" Postural Tremor
score on a scaleTAPS StimulationSham Stimulation
Baseline2.29 ± 0.702.16 ± 0.57
Change during stimulation-0.51 ± 0.70-0.34 ± 0.44
Other pre-specifiedChange in Forward Outstretched Postural Tremor

The change in tremor severity on outstretched tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.

Time frame:
Immediately before and after 40 minute stimulation session
Reported as:
Mean · score on a scale
Change in Forward Outstretched Postural Tremor
score on a scaleTAPS StimulationSham Stimulation
Baseline1.96 ± 0.541.91 ± 0.54
Change after stimulation-0.75 ± 0.65-0.35 ± 0.51
Other pre-specifiedChange in Forward Outstretched Postural Tremor

The change in tremor severity on outstretched tremor task as assessed by an investigator using the TETRAS rating scale. The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.

Time frame:
Immediately before and 30 minutes into stimulation session
Reported as:
Mean · score on a scale
Change in Forward Outstretched Postural Tremor
score on a scaleTAPS StimulationSham Stimulation
Baseline1.96 ± 0.541.91 ± 0.54
Change during stimulation-0.56 ± 0.59-0.35 ± 0.41
Other pre-specifiedChange in Bain & Findley ADL: Use a Spoon to Drink Liquid

The change in tremor severity on drinking liquid with a spoon as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.

Time frame:
Immediately before and after 40 minute stimulation session
Reported as:
Mean · score on a scale
Change in Bain & Findley ADL: Use a Spoon to Drink Liquid
score on a scaleTAPS StimulationSham Stimulation
Baseline3.18 ± 0.783.00 ± 0.85
Change after stimulation-0.78 ± 0.89-0.59 ± 0.76
Other pre-specifiedChange in Bain & Findley ADL: Hold a Cup of Liquid

The change in tremor severity on holding a cup of liquid as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.

Time frame:
Immediately before and after 40 minute stimulation session
Reported as:
Mean · score on a scale
Change in Bain & Findley ADL: Hold a Cup of Liquid
score on a scaleTAPS StimulationSham Stimulation
Baseline2.95 ± 0.852.65 ± 0.92
Change after stimulation-1.03 ± 0.73-0.57 ± 0.80
Other pre-specifiedChange in Bain & Findley ADL: Pouring

The change in tremor severity on pouring as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.

Time frame:
Immediately before and after 40 minute stimulation session
Reported as:
Mean · score on a scale
Change in Bain & Findley ADL: Pouring
score on a scaleTAPS StimulationSham Stimulation
Baseline2.78 ± 1.032.59 ± 0.86
Change after stimulation-0.70 ± 0.76-0.59 ± 0.72
Other pre-specifiedChange in Bain & Findley ADL: Dialing

The change in tremor severity on dialing a telephone as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.

Time frame:
Immediately before and after 40 minute stimulation session
Reported as:
Mean · score on a scale
Change in Bain & Findley ADL: Dialing
score on a scaleTAPS StimulationSham Stimulation
Baseline2.23 ± 0.892.00 ± 0.91
Change after stimulation-0.70 ± 0.79-0.30 ± 0.62
Other pre-specifiedChange in Bain & Findley ADL: Picking up Change

The change in tremor severity on picking up change as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.

Time frame:
Immediately before and after 40 minute stimulation session
Reported as:
Mean · score on a scale
Change in Bain & Findley ADL: Picking up Change
score on a scaleTAPS StimulationSham Stimulation
Baseline2.03 ± 0.861.92 ± 0.89
Change after stimulation-0.53 ± 0.68-0.05 ± 0.62
Other pre-specifiedChange in Bain & Findley ADL: Inserting Plug Into Socket

The change in tremor severity on inserting a plug into a socket as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.

Time frame:
Immediately before and after 40 minute stimulation session
Reported as:
Mean · score on a scale
Change in Bain & Findley ADL: Inserting Plug Into Socket
score on a scaleTAPS StimulationSham Stimulation
Baseline1.83 ± 0.781.76 ± 0.80
Change after stimulation-0.33 ± 0.69-0.24 ± 0.55
Other pre-specifiedChange in Bain & Findley ADL: Unlocking

The change in tremor severity on unlocking a lock with a key as assessed by the subject using the Bain \& Findley ADL rating scale. The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.

Time frame:
Immediately before and after 40 minute stimulation session
Reported as:
Mean · score on a scale
Change in Bain & Findley ADL: Unlocking
score on a scaleTAPS StimulationSham Stimulation
Baseline2.23 ± 0.861.86 ± 0.67
Change after stimulation-0.60 ± 0.87-0.16 ± 0.55

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
TAPS Stimulation—0/48 (0%)2/48 (4.2%)
Sham Stimulation—0/45 (0%)1/45 (2.2%)
Most frequent other events
Most frequent other events
EventTAPS StimulationSham Stimulation
Skin IrritationSkin and subcutaneous tissue disorders2/480/45
Stinging pain in wristSkin and subcutaneous tissue disorders0/481/45
Feeling of weakness around the wristNervous system disorders1/480/45

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)TAPS StimulationSham StimulationTotal
<=18 years000
Between 18 and 65 years121224
>=65 years363369
Age, Continuous
Age, Continuous(years)TAPS StimulationSham StimulationTotal
Mean70.5 ± 11.269.8 ± 10.170.2 ± 10.6
Sex: Female, Male
Sex: Female, Male(Participants)TAPS StimulationSham StimulationTotal
Female252348
Male232245
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)TAPS StimulationSham StimulationTotal
Hispanic or Latino202
Not Hispanic or Latino454590
Unknown or Not Reported101
Race (NIH/OMB)
Race (NIH/OMB)(Participants)TAPS StimulationSham StimulationTotal
American Indian or Alaska Native011
Asian011
Native Hawaiian or Other Pacific Islander000
Black or African American000
White474188
More than one race123
Unknown or Not Reported000
08

Study locations

4 sites
  • UCSF
    San Francisco, California 94121, United States
  • The Parkinson's Institute
    Sunnyvale, California 94085, United States
  • Kansas University Medical Center
    Kansas City, Kansas 66103, United States
  • Swedish Medical Center Seattle
    Seattle, Washington 98122, United States
09

References and documents

Individual participant data

Plan to share: No — Data will be published, but no PHI will be made available.

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2016, a primary completion of Nov 2016 and a completion of Nov 2016. It does not say whether these dates are actual or estimated.

Results were first posted in Jul 2023, 6 years 8 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 8, 2015
First posted
Dec 14, 2015
Start
Apr 2016
Primary completionActual
Nov 2016
CompletionActual
Nov 2016
Results first posted
Jul 18, 2023
Last update
Jul 18, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02629614
Lead sponsor
Cala Health, Inc.
Responsible party
Sponsor
First posted
Dec 14, 2015
Start date
Apr 2016
Primary completion
Nov 2016
Completion
Nov 2016
Results posted
Jul 18, 2023
Last update
Jul 18, 2023

Study contacts

Lin, MD
study chair · Clinical Advisor

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion